Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $0.11.

  • Organogenesis Holdings' EPS (Basic) rose 2222.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 10000.0%. This contributed to the annual value of -$0.01 for FY2024, which is 11779.02% down from last year.
  • Per Organogenesis Holdings' latest filing, its EPS (Basic) stood at $0.11 for Q3 2025, which was up 2222.22% from -$0.1 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' EPS (Basic) ranged from a high of $0.39 in Q4 2021 and a low of -$0.17 during Q1 2025
  • Over the past 5 years, Organogenesis Holdings' median EPS (Basic) value was $0.04 (recorded in 2023), while the average stood at $0.04.
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 113085.93% in 2024, then tumbled by 75000.0% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' EPS (Basic) stood at $0.39 in 2021, then crashed by 84.62% to $0.06 in 2022, then plummeted by 107.21% to -$0.0 in 2023, then soared by 1130.86% to $0.04 in 2024, then soared by 146.54% to $0.11 in 2025.
  • Its EPS (Basic) stands at $0.11 for Q3 2025, versus -$0.1 for Q2 2025 and -$0.17 for Q1 2025.